# Effects of IAP-EOGBSD on Offspring's Gut Microbiome and Immunity.

> **NCT05738460** · — · UNKNOWN · sponsor: **Zhujiang Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Healthy
- Metabolism
- Microbiome

## Interventions

- **DRUG:** antibiotics

## Key facts

- **NCT ID:** NCT05738460
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-23
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2023-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05738460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05738460, "Effects of IAP-EOGBSD on Offspring's Gut Microbiome and Immunity.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05738460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*